We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Datatrak files patent infringement suit against Medidata

Datatrak files patent infringement suit against Medidata

June 8, 2011
CenterWatch Staff

Medidata Solutions faces a patent infringement lawsuit from a smaller competitor in the clinical trials software business, according to Fierce BiotechIT. Cleveland-based Datatrak International said it has served a complaint to Medidata for alleged unauthorized use of its intellectual property.

Medidata revealed to regulators last month that Datatrak had filed such a complaint on March 4 in U.S. District Court for the Northern District of Ohio. Datatrak said today that Medidata's Rave product infringes on its patent for "methods and systems for unifying data from a plurality of heterogeneous databases with each having business-context related data and a data access mechanism."

While patent infringement suits are filed all the time in the IT world, this one comes as Medidata continues to distance itself from competitors in the electronic data capture (EDC) business. And if the New York-based company is a target for litigation, it's certainly becoming a bigger target. Its customer base has grown from 92 at the start of 2008 to 232 at the end of the first quarter of 2011, as more drug developers and life sciences companies use its web-based system for managing data in clinical trials.

Still, Datatrak seems poised for a legal battle with its larger competitor. "The patent is an important asset in Datatrak's technology portfolio, and we vigorously protect our intellectual property," Laurence Birch, chairman and CEO, said in a statement.

"After months of attempting, with little success, to engage proactively with Medidata and its counsel, it has become clear that the only way we will be able to obtain any relief from this apparent infringement is through litigation," Birch said. "We will seek both injunctive and monetary relief, asking the Court to order Medidata to cease all activities that violate Datatrak's intellectual property rights and to pay damages for its infringement."

 

United States Technology Solutions
  • Related Directories

    Complion

    IRBNet

    CROMSOURCE

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing